PMID: 9548602Apr 21, 1998Paper

Isolated limb perfusion in primary and recurrent melanoma: indications and results

Seminars in Surgical Oncology
D LiénardF J Lejeune

Abstract

In advanced melanoma of the limbs with in-transit metastasis, melphalan with isolated limb perfusion (M-ILP) produces around 50% complete remissions (CR). The combination of melphalan with tumour necrosis factor-alpha (TNFalpha) and interferon-gamma (IFNgamma) in isolated limb perfusion (TIM-ILP) gives around 80% CR. A prospective randomised phase II study compared 32 patients who received TIM-ILP with 32 patients who received TM-ILP (without IFNgamma). The overall remission rate (ORR) and the CR rate were superior with TIM-ILP as compared to TM-ILP, 100% vs. 91% and 78% vs. 69% respectively, but the differences are not significant. Given the efficacy of M-ILP on in-transit metastasis, the procedure was tested as an adjunct to surgery in high-risk (Breslow > or = 1.5 mm) primary melanoma of the limbs. Through the combined effort of the melanoma groups of the European Organization for Research and Treatment of Cancer (EORTC), the World Health Organization (WHO), and the North American Perfusion Group, 832 evaluable patients from 16 centres were entered in a phase III study. Median followup is 6.4 years. There was a trend for a longer disease-free interval after M-ILP. The difference is significant if the patients without electiv...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Mar 1, 1992·World Journal of Surgery·H Schraffordt KoopsH J Hoekstra
Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D LienardF J Lejeune
Nov 8, 1985·Science·L J Old
Jun 25, 1985·Nucleic Acids Research·L FransenA Van Vliet
Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L ShermanD W Kufe
Dec 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P B ChapmanH F Starnes
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D PennicaD V Goeddel
Jan 1, 1983·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·F J LejeuneA Verhest
Oct 1, 1982·European Journal of Cancer & Clinical Oncology·J WieberdinkG A Olthuis
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F J Lejeune
Jul 1, 1995·The Journal of Pathology·N RenardD J Ruiter
Sep 1, 1993·The British Journal of Surgery·J M KlaaseH R Franklin
Oct 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M EggermontF J Lejeune
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T BrodowiczP Ritschl
Jan 24, 1959·Journal of the American Medical Association·O CREECHE T KREMENTZ

❮ Previous
Next ❯

Citations

Nov 9, 2006·Cancer Chemotherapy and Pharmacology·Paul H Sugarbaker, O Anthony Stuart
Aug 10, 2000·Current Surgery·R B Redd, F L Greene
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
May 30, 2008·Annals of Surgical Oncology·Hidde M KroonJohn F Thompson
May 10, 2011·Current Problems in Surgery·Amira SankiJohn F Thompson
Dec 18, 2008·Cancer·Anita TandleSteven K Libutti
Nov 17, 2009·Advanced Drug Delivery Reviews·Paul CherukuriSteven A Curley
Apr 15, 2009·Journal of Surgical Oncology·Hidde M Kroon, John F Thompson
Jan 12, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M R KapmaB B R Kroon
May 26, 2009·Journal of Vascular and Interventional Radiology : JVIR·Carmel G CroninGerard J O'Sullivan
Jun 30, 2000·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A J BremersG Parmiani
Nov 18, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C KnorrW Hohenberger
Nov 25, 2004·The Annals of Thoracic Surgery·Jeroen M H HendriksPaul E Y Van Schil
Jan 25, 2000·Cancer Treatment Reviews·A J BremersC J van de Velde
Oct 26, 2006·Nature Reviews. Immunology·Gavin P DunnRobert D Schreiber
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie A EllerhorstElizabeth A Grimm
Mar 30, 2004·Cancer Chemotherapy and Pharmacology·O GlehenP H Sugarbaker
Jan 27, 2010·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Cedric E BoeschChristian Knorr
May 8, 2003·Annals of Surgical Oncology·Faheez MohamedPaul H Sugarbaker
May 2, 2008·International Journal of Cancer. Journal International Du Cancer·Chandrakala MenonDouglas L Fraker
Jan 23, 2010·Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række·Kari Dolven JacobsenStein Gundersen
Sep 1, 2019·Annals of Surgical Oncology·Georgia M BeasleyJohn F Thompson
Mar 13, 2002·Annals of Surgical Oncology·Per LindnérJohn F Thompson
Nov 14, 2007·Journal of Surgical Oncology·Marco Jj H GrootenboersFranz Mnh Schramel
Apr 16, 2002·Seminars in Oncology·David M Weinreich, H Richard Alexander

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.